FSH= Focal and segmental hyalinosis; FSGS = focal and segmental glomerulosclerosis; CRF = chronic renal failure; MGN = membranous glomerulonephritis; NCGN = necrotising and crescentic glomerulonephritis; St. = staining pattern; p = perinuclear; c = cytoplasmic; PR-3 = proteinase-3; ND = not done; H = homogeneous; S = speckled; ENA = antibodies against extractable nuclear antigens; RF = rheumatoid factor; NI = not identified.
Since then, two additional patients with silicon nephropathy and MPO-ANCA have been found: one had a membranous glomerulonephritis and the other a necrotising crescentic glomerulonephritis (NCGN). For the latter (No 5 in the table), MPO-ANCA were already present in a 10 year old frozen serum sample. In addition, three other patients with renal disease (one with FSGS and two with NCGN) having MPO-ANCA were exposed to silica without documented lung disease. Indeed, the overall incidence of patients with silica exposure and renal involvement among our ANCA-positive patients is 5-5% (eight of 145). All had MPO-ANCA whatever the staining pattern; it is now well known that some MPO-ANCA may have a c-ANCA staining pattern. 5 In Table 1 shows the demographic and clinical characteristics of the patients. In 18 patients (38%), at least one EAM was observed, nodulosis being the most common (observed in 17 patients). In 39 patients (83%), at least one comorbid condition was noted; hypertension was the most common (present in 14 patients). Physician's assessment of RA was the most highly intercorrelated measure in assessing patients when correlated with HAQ (r=0 5, p=0-001), patient's assessment of pain (r = 0-6, p = 0-0001), and swollen joint count (r= 0-4, p = 0 004). Formal educational level, marital status, employment, and presentation of RA had no impact on the outcome (disability) of the disease (table 2) . There were no significant differences in the independent comparison between clinical factors regarding the presence of RF but, after adjusting for clinical cofactors (age, duration of disease, physician's assessment of RA, swollen joint count, ESR, and EAM), an association between seropositive RF and HAQ .1-37 was observed (odds ratio 12-3, 95% confidence interval 1 1 to 135, p = 004). In 34 patients methotrexate (MTX) was administered (dose: 11-3 (4) mg/week, mean duration 23-4 months). Four patients discontinued MTX because of side effects; increasing age was the main factor associated with toxicity and permanent discontinuation. After adjustments for age, the cumulative probability of continuing to take MTX at one and five years was 89% and 84%, respectively. Because more than 95% of the population attending The Charity Hospital are black Americans, we were unable to study a control group. Despite the study size, our results suggest that, in our black American population, RA is less severe, in terms of disability and presence of EAM, than in white patients and a previous series reported in black Americans.2 8 These results are in agreement with other published studies in black African RA patients, but contrast with studies in the urban South African Bantu people. ' 9 We found that the presence of RF was a modifying factor of outcome, while those demographic variables analysed were not. MTX treatment was well tolerated.
Predictors of worsening clinical variables and outcomes in RA have been reviewed by Pincus and Callahan'" and Furst." They include genetic factors, female gender, number of swollen joints, subcutaneous nodules, RF positivity, early erosions, low formal education level, single marital status, and unemployment.'' " Factors which could explain the differences observed in the present study include genetic, ethnic, geographic, and environmental factors.' 12 13 It should be taken into consideration also that our population was seen, on average, once every two months; this may be associated with a greater likelihood of improvement in disability.'4 Lastly, the potential role of MTX treatment in altering the natural course of the disease deserves some consideration; 72% of our patients were treated with MTX. Our results also extend the observations in previous studies showing that black Americans and younger patients seem to have a better probability of continuing MTX treatment. ' We describe here the case of a woman suffering from psoriatic SpA and showing dactylitis of the middle finger also involving an uncommon anatomical feature of synovial sheaths communicating with the ulnar palmocarpal sheaths. To our knowledge there are no previous report of this situation. A 37 year old woman was referred to our Rheumatic Disease Unit in May 1993 for evaluation of a two year history of pain and swelling in the middle finger extending into the palm of the left hand. Her medical history disclosed that she had been affected by psoriasis for 31 years and had suffered from numerous episodes of buttock pain and inflammatory low back pain and stiffness during the previous 21 years. In the past few years, the pain had extended to the cervical
